PBH — Prestige Consumer Healthcare Inc.

Summary of Prestige Consumer Healthcare (PBH) Q4 2026 Earnings Call

1. Key Financial Results and Metrics

• Q4 Revenue: $281.6 million, down 5% from $296.5 million year-over-year; down 6.4% excluding foreign exchange effects.
• Full Year Revenue: Declined approximately 4.5% organically.
• Adjusted EPS: $4.38, down from $4.52 in the prior year.
• Adjusted Gross Margin: 55.6%, approximately flat compared to 55.8% in the previous year.
• Free Cash Flow: Approximately $246 million, a slight increase from the prior year.
• Net Debt: Approximately $900 million with a leverage ratio of 2.6x.

2. Strategic Updates and Business Highlights

• Acquisitions: Completed the acquisition of Pillar5 to enhance eye care production capabilities. Two pending acquisitions include Breathe Right and LaCorium Health, expected to close in mid-2027.
• Brand Performance: Strong performance in GI franchises (Dramamine, Fleet, Hydralyte) and stabilization in Women's Health (Summer's Eve, Monistat).
• E-commerce Growth: E-commerce penetration reached approximately 18%, with double-digit consumption growth.
• Production Initiatives: Focus on improving production volume and supply consistency, particularly in Eye Care.

3. Forward Guidance and Outlook

• Fiscal 2027 Revenue Forecast: Expected between $1.1 billion to $1.12 billion, with organic growth of approximately 1% to 3%.
• Adjusted EPS Guidance: Projected between $4.42 to $4.51.
• Free Cash Flow Expectation: Anticipated to exceed $250 million.
• Long-term Growth Outlook: Aiming for a sales CAGR of approximately 10% through fiscal 2029, driven by acquisitions and recovery in eye care.

4. Bad News, Challenges, or Points of Concern

• Q4 Performance: Results fell short of expectations, primarily due to supply chain disruptions in Eye Care and international shipping delays related to geopolitical events.
• Production Issues: Clear Eyes sales were impacted by delayed shipments and production shutdowns for upgrades, leading to uncertainty in recovery timelines.
• Consumer Environment: Ongoing macroeconomic pressures, including inflation and geopolitical tensions, create a challenging consumer landscape.
• Market Competition: Recent recalls in the eye care industry present both risks and opportunities, as competitors face quality issues.

5. Notable Q&A Insights

• Eye Care Recovery: Management expressed confidence in returning to growth in Eye Care, with expectations for improved production in the second half of fiscal 2027.
• M&A Execution: Confidence in managing multiple acquisitions simultaneously, with no significant overlap in integration resources.
• Consumer Behavior: Consumers remain loyal to trusted brands, which may mitigate some impacts of economic volatility.
• Pricing Strategy: Anticipated limited pricing power in the near term, with volume expected to drive growth.

Overall, while PBH faced challenges in Q4 2026, management remains optimistic about future growth driven by strategic acquisitions and a diverse brand portfolio. The company is focused on improving production and navigating a complex consumer environment.